Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is an increase over the number of companies cited in the previous quarter.
The citations in the county include:
- There is no record maintained of a correction or removal action that was not required to be reported to FDA.
- A process whose results cannot be fully verified by subsequent inspection and test has not been validated according to established procedures.
- Corrective and preventive action activities and/or results have not been documented.
The company cited should take a voluntary action to correct its managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Prentke Romich Company | Devices | 05/01/2025 | Records not kept |
Prentke Romich Company | Devices | 05/01/2025 | Lack of or inadequate process validation |
Prentke Romich Company | Devices | 05/01/2025 | Documentation |
Prentke Romich Company | Devices | 05/01/2025 | Lack of or inadequate DHR procedures |
Prentke Romich Company | Devices | 05/01/2025 | Lack of or inadequate complaint procedures |